2016
DOI: 10.1590/s0100-736x2016000900006
|View full text |Cite
|
Sign up to set email alerts
|

Uso de antimicrobiano nanoparticulado para o tratamento da mastite subclínica de ovelhas de corte no período seco

Abstract: Resumo: A inflamação da glândula mamária é uma das principais causas de prejuízo na ovinocultura. Este estudo teve como objetivo investigar as taxas de cura do tratamento da mastite subclínica após infusão intramamária de princípio ativo antimicrobiano no momento da secagem, em formulações convencional e nanoparticulada. Os rebanhos estavam localizados em São Carlos, São Paulo, Brasil. Analisou-se um total de 584 glândulas mamárias de 307 ovelhas de aptidão para produção de carne. Triagem prévia dos casos subc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 19 publications
(14 reference statements)
0
2
0
1
Order By: Relevance
“…Parenteral administration of drug-loaded pbENPs in mastitic cows, sheep, or goats [114] could increase the risk for consumers through milk consumption as compared to non-nano delivery methods, where residue elimination time is clearly established. Other examples include a product that was approved for livestock use by UE's Committee for Medicinal Products for Veterinary Use (CVMP) in 2015 and by the US Food and Drug Administration (FDA) in 2016.…”
Section: Hormone Loaded Pbenpsmentioning
confidence: 99%
“…Parenteral administration of drug-loaded pbENPs in mastitic cows, sheep, or goats [114] could increase the risk for consumers through milk consumption as compared to non-nano delivery methods, where residue elimination time is clearly established. Other examples include a product that was approved for livestock use by UE's Committee for Medicinal Products for Veterinary Use (CVMP) in 2015 and by the US Food and Drug Administration (FDA) in 2016.…”
Section: Hormone Loaded Pbenpsmentioning
confidence: 99%
“…These findings suggest that the nanoencapsulation of toltrazuril made it possible to halve its dose for the treatment of coccidiosis, since the same response was observed in comparison with the reference medicine. In this context, the ability of nanoencapsulation to reduce drug dose was already evidenced in other studies, such as for PCL nanocapsules containing curcumin in the treatment of glioma in rats [27] and cloxacillin in the treatment of mastitis in sheep [38]. Moreover, to the best of our knowledge, this is the first report that evaluated polymeric nanocapsules containing an anticoccidial drug (toltrazuril), being a promising approach for the prophylactic control of Eimeria spp.…”
Section: Mucosal Sample Analysismentioning
confidence: 52%
“…De acordo com Santana et al (2016) o processo inflamatório na glândula mamária desencadeado em resposta a um microrganismo invasor pode ser efetivo no combate à infecção, mas como esse efeito não é o suficiente para todos os casos, a medida mais comum no controle da mastite é o tratamento com antimicrobianos (Almeida et al, 1999).…”
Section: Mastiteunclassified